VEGFA and neoplasm: Our study showed that SHMT2decreased tumor cell survival by affecting HIF1α expression, which, in turn, altered the downstream VEGF–STAT3 pathway.Concerning how SHMT2 affected HIF1α, we identified SHMT2’s enzymatic and non-enzymatic roles as contributing to its effect.